companies:
9,734
total market cap:
โฌ100.279 T
Sign in
โฌ EUR
$
USD
๐บ๐ธ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
This company seems to have been delisted
Reason: Delisted by Nasdaq
Last recorded trade on: February 22, 2023
Source:
https://www.globenewswire.com/en/news-release/2022/12/28/2580400/6948/en/Delisting-of-Securities-of-Tuscan-Holdings-Corp-II-Clovis-Oncology-Inc-ZyVersa-Therapeutics-Inc-Otonomy-Inc-and-Forward-Pharma-A-S-from-The-Nasdaq-Stock-Market.html
Clovis Oncology
CLVS
#9386
Rank
โฌ10.62 M
Marketcap
๐บ๐ธ
USA
Country
0,07327ย โฌ
Share price
0.00%
Change (1 day)
-95.26%
Change (1 year)
๐ Pharmaceuticals
๐งฌ Biotech
Categories
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
Fails to deliver
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating Margin
EPS
Shares outstanding
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Clovis Oncology (CLVS) Fails to deliver data
Key failure to deliver metrics for Clovis Oncology:
Last
SEC
data release:
2022-12-14
Last 15 days FTD volume: โฌ0.12 M
Last 3 months FTD volume: โฌ7.84 M
Last year FTD volume: โฌ96.73 M
A Failure to deliver also known as fails-to-deliver or
FTD
occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the
SEC
and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Clovis Oncology (CLVS) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Clovis Oncology (CLVS) - since 2013
Volume in
USD
(price x number of shares), data since 2013
Clovis Oncology (CLVS) Failure to deliver volume, Year over Year
Year
Volume (Price x Shares)
Change
2022
โฌ0.10 B
55.95%
2021
โฌ64.22 M
-74.65%
2020
โฌ0.25 B
-49.12%
2019
โฌ0.49 B
1053.83%
2018
โฌ43.14 M
68.49%
2017
โฌ25.6 M
-50.75%
2016
โฌ51.99 M
5.81%
2015
โฌ49.14 M
-8.09%
2014
โฌ53.46 M
1150.43%
2013
โฌ4.27 M
FTD volume in the last 3 months for similar companies or competitors
Company
FTD volume (3months)
FTD volume (1 year)
Country
BioMarin Pharmaceutical
BMRN
โฌ10.67 M
โฌ16.3 M
๐บ๐ธ
USA
AstraZeneca
AZN
โฌ13.08 M
โฌ0.14 B
๐ฌ๐ง
UK
Pfizer
PFE
โฌ0.24 B
โฌ0.50 B
๐บ๐ธ
USA
Johnson & Johnson
JNJ
โฌ90.55 M
โฌ0.28 B
๐บ๐ธ
USA
AbbVie
ABBV
โฌ77.32 M
โฌ0.11 B
๐บ๐ธ
USA
Eli Lilly
LLY
โฌ39.92 M
โฌ0.13 B
๐บ๐ธ
USA